Science
Innovation in the drug discovery pipeline
Science
Acellera is actively involved in research and development. Since 2006 we support applied research for the development of biomedical simulation methods via agreements with academic institutions.
Furthermore, Acellera creates new software and hardware infrastructure for performing biomolecular simulations in high-throughput. Salient examples are Metrocubo, the Acellera GPU chassis, and the AceCloud interface. The latter two examples are currently patent pending
We would be happy to consider scientific collaborations with interested parties to demonstrate the potentiality of biomolecular simulations. We are open to research projects (e.g. European projects) as well as other collaboration formats.
Acellera research
Click on the categories to see Acellera’s research on that topic.
Applications
Conformational studies
Protein-Ligand Binding
Membrane Proteins
Theory
ACEMD
HTMD
ACECLOUD
Fragment Based
Selected Publications
Ongoing international and EU funded projects
CompBioMed
A Centre of Excellence in Computational Biomedicine. H2020-EINFRA-2015-1, Grant Agreement nr. 675451. 2016-2019
HTMD
Feasibility assessment of a cloud application platform for rational drug design using high-throughput. H2020 SME Instrument 2014, Grant Agreement nr. 674659. 2015
CCFBLD-CHEMO
Computer-Centric Fragment Based Ligand Discovery for the Development of candidate molecules targeting the chemkine system. Nuclis d’Innovació Tecnològica 2014. Acció, Generalitat de Catalunya. Nuclis Transnacionals Programa Bilateral Catalunya-Israel, Project nr. RDIS14-1-0002. 2014-2016
Cloud-HTMD
A cloud application platform for rational drug discovery using high throughput molecular dynamics; European SME innovation Associate(H2020-INNOSUP-02-2016, Grant Agreement 739649)
